Biophytis Achieves Legal Victory in Court of Cassation

Biophytis SA, a biotechnology firm based in Paris and Cambridge, has secured a significant legal win. The French Court of Cassation partly overturned a previous ruling that favored Negma Group against Biophytis. This decision arose from a dispute over a convertible bond agreement dating back to August 2019, which had severely impacted Biophytis financially and reputationally.

The Court of Cassation questioned the legality of Negma Group's actions, suggesting potential unauthorized investment service activities. The case is now referred to a newly composed court chamber, offering a fresh perspective on the issues at hand.

This marks an important step towards validating Biophytis’ claims of irregular conduct by Negma Group. The ruling aligns with Biophytis' continuous stance since the dispute's inception. The company expresses confidence in using this decision to support its future strategies and protect shareholder interests.